Cargando…

Paul Workman: Drugging the Cancer Genome

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118434/
https://www.ncbi.nlm.nih.gov/pubmed/27904887
http://dx.doi.org/10.1016/j.trecan.2016.10.004
_version_ 1782468929963163648
collection PubMed
description
format Online
Article
Text
id pubmed-5118434
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Cell Press
record_format MEDLINE/PubMed
spelling pubmed-51184342016-11-28 Paul Workman: Drugging the Cancer Genome Trends Cancer TrendsTalk Cell Press 2016-10 /pmc/articles/PMC5118434/ /pubmed/27904887 http://dx.doi.org/10.1016/j.trecan.2016.10.004 Text en © 2016 Institute of Cancer Research. Published by Elsevier Ltd. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle TrendsTalk
Paul Workman: Drugging the Cancer Genome
title Paul Workman: Drugging the Cancer Genome
title_full Paul Workman: Drugging the Cancer Genome
title_fullStr Paul Workman: Drugging the Cancer Genome
title_full_unstemmed Paul Workman: Drugging the Cancer Genome
title_short Paul Workman: Drugging the Cancer Genome
title_sort paul workman: drugging the cancer genome
topic TrendsTalk
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118434/
https://www.ncbi.nlm.nih.gov/pubmed/27904887
http://dx.doi.org/10.1016/j.trecan.2016.10.004